Excelsior Sciences
Automated Small Molecule Discovery & Manufacturing
New York, United States · $95.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Business Model
- B2B
- Website
- excelsiorsci.com
- Total Funding
- $95.0M
- Last Round
- $70.0M Series ADec 2025
- Rounds
- 2
About
Excelsior Sciences uses automated blocc chemistry and AI to accelerate small molecule drug discovery and scale from molecule to medicine.
Summary
Excelsior Sciences is a Biotech company based in New York, United States. It has raised $95.0M in total across 2 rounds, most recently a $70.0M Series A round in Dec 2025. Investors include Deerfield Management, Khosla Ventures and Sofinnova Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Sign up to see all 2 rounds
Series A through Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/excelsior-sciences"><img src="https://indexed.vc/api/badge/company/excelsior-sciences" alt="Excelsior Sciences on Indexed.vc" width="260" height="76" /></a>